Search alternatives:
significant source » significant burden (Expand Search), significant cause (Expand Search)
decrease » decreased (Expand Search), increase (Expand Search)
Showing 1 - 20 results of 6,127 for search '(( significant positive breast ) OR ( significant source decrease ))', query time: 0.47s Refine Results
  1. 1
    BLyS<sup>-/-</sup> significantly decreased IgM and IgG secreting cells.

    BLyS<sup>-/-</sup> significantly decreased IgM and IgG secreting cells. by Natalie M. Bath (6316517)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 2
    MAF1 protein expression is significantly decreased in luminal, HER2-positive, and TNBC breast cancer subtypes.

    MAF1 protein expression is significantly decreased in luminal, HER2-positive, and TNBC breast cancer subtypes. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 3
    Sampling point (Source:

    Sampling point (Source: by Yonggang Huang (223155)

    Published 2025
    Save to List
    Saved in:
  4. 4
    APRIL<sup>-/-</sup> and BLyS<sup>-/-</sup> lymphocyte proliferation significantly decreased when challenged with alloantigen.

    APRIL<sup>-/-</sup> and BLyS<sup>-/-</sup> lymphocyte proliferation significantly decreased when challenged with alloantigen. by Natalie M. Bath (6316517)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 5
    Transcriptionally-inferred PI3K pathway activation and breast tumor stemness/grade exhibit significant, positive association.

    Transcriptionally-inferred PI3K pathway activation and breast tumor stemness/grade exhibit significant, positive association. by Ralitsa R. Madsen (11681590)

    Published 2021
    Save to List
    Saved in:
  6. 6
    Metadata supporting the published article: Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer

    Metadata supporting the published article: Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer by Olga Kantor (9119030)

    Published 2020
    Save to List
    Saved in:
  7. 7
    KCNK1 overexpression is significantly associated with breast cancer cells invasion and metastasis markers.

    KCNK1 overexpression is significantly associated with breast cancer cells invasion and metastasis markers. by Xiangchan Hou (18864991)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 8
    Variants of uncertain significance.

    Variants of uncertain significance. by Ghada Al-Kafaji (12054792)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 9
    Expression and clinical significance of PFKP in breast cancer.

    Expression and clinical significance of PFKP in breast cancer. by Danna Yeerken (8911448)

    Published 2020
    Save to List
    Saved in:
  10. 10
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  11. 11
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  12. 12
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  13. 13
    Texture features with statistically significant differences between HER2 2+ positive and negative patients for subtraction images.

    Texture features with statistically significant differences between HER2 2+ positive and negative patients for subtraction images. by Lirong Song (458651)

    Published 2020
    Save to List
    Saved in:
  14. 14
    A 71-year-old woman with true-positive bone metastases.

    A 71-year-old woman with true-positive bone metastases. by Jeanette Ansholm Hansen (11726084)

    Published 2021
    Save to List
    Saved in:
  15. 15
    A 54-year-old woman with true-positive bone metastases.

    A 54-year-old woman with true-positive bone metastases. by Jeanette Ansholm Hansen (11726084)

    Published 2021
    Save to List
    Saved in:
  16. 16
    BMR decreases with age.

    BMR decreases with age. by Henrik H. Berntsen (11767710)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 17
    Image_1_Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.tif

    Image_1_Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.tif by Yu Tang (343157)

    Published 2022
    “…Background<p>After early-line (first- and second-line) endocrine therapy, hormone-receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancers (mBCs) become resistant to endocrine therapy. …”
    Save to List
    Saved in:
  18. 18
    Image_2_Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.tif

    Image_2_Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.tif by Yu Tang (343157)

    Published 2022
    “…Background<p>After early-line (first- and second-line) endocrine therapy, hormone-receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancers (mBCs) become resistant to endocrine therapy. …”
    Save to List
    Saved in:
  19. 19
    Table_1_Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.docx

    Table_1_Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC.docx by Yu Tang (343157)

    Published 2022
    “…Background<p>After early-line (first- and second-line) endocrine therapy, hormone-receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancers (mBCs) become resistant to endocrine therapy. …”
    Save to List
    Saved in:
  20. 20
    KCNK1 and downstream proteins are positively correlated in clinical breast cancer samples.

    KCNK1 and downstream proteins are positively correlated in clinical breast cancer samples. by Xiangchan Hou (18864991)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: